Related Experiment Video
Updated: Feb 2, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia
Brittani R Price1, Donna M Wilcock1, Erica M Weekman1
1Department of Physiology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States.
Insights
Hyperhomocysteinemia (HHcy), a risk factor for vascular contributions to cognitive impairment and dementia (VCID), is linked to B vitamin deficiency. Lowering homocysteine via B vitamin supplementation shows conflicting results in clinical trials for treating HHcy-induced VCID.
Area of Science:
- Neurology
- Gerontology
- Biochemistry
Background:
- Vascular contributions to cognitive impairment and dementia (VCID) is the second leading cause of dementia, impacting 10-40% of patients.
- Hyperhomocysteinemia (HHcy), elevated plasma homocysteine levels, is an underrecognized major risk factor for VCID.
- B vitamin deficiency, a common cause of HHcy, is prevalent in the elderly population.
Purpose of the Study:
- To review HHcy as a significant risk factor for VCID.
- To explore proposed mechanisms underlying homocysteine-induced cognitive decline.
- To examine clinical trials investigating the efficacy of lowering plasma homocysteine for VCID.
Main Methods:
- Review of preclinical studies (cell culture, animal models) on homocysteine's mechanisms.
- Analysis of clinical trial data on B vitamin supplementation for lowering homocysteine.
- Focus on study design challenges and conflicting results in therapeutic interventions.
Main Results:
- Conflicting results from clinical trials on B vitamin supplementation for reducing homocysteine and improving cognitive function.
- Proposed mechanisms in preclinical studies suggest various pathways for homocysteine-induced neurotoxicity.
- Challenges in study design have impacted the interpretation of therapeutic benefits.
Conclusions:
- Despite B vitamin supplementation's safety and low cost, its effectiveness in treating HHcy-induced VCID remains uncertain due to conflicting clinical trial outcomes.
- Understanding the diverse mechanisms of homocysteine's neurotoxicity is crucial for developing targeted therapies.
- Further research with optimized study designs is needed to clarify the role of homocysteine lowering in VCID prevention and treatment.
Abstract:
Behind only Alzheimer's disease, vascular contributions to cognitive impairment and dementia (VCID) is the second most common cause of dementia, affecting roughly 10-40% of dementia patients. While there is no cure for VCID, several risk factors for VCID, such as diabetes, hypertension, and stroke, have been identified. Elevated plasma levels of homocysteine, termed hyperhomocysteinemia (HHcy), are a major, yet underrecognized, risk factor for VCID. B vitamin deficiency, which is the most common cause of HHcy, is common in the elderly. With B vitamin supplementation being a relatively safe and inexpensive therapeutic, the treatment of HHcy-induced VCID would seem straightforward; however, preclinical and clinical data shows it is not. Clinical trials using B vitamin supplementation have shown conflicting results about the benefits of lowering homocysteine and issues have arisen over proper study design within the trials. Studies using cell culture and animal models have proposed several mechanisms for homocysteine-induced cognitive decline, providing other targets for therapeutics. For this review, we will focus on HHcy as a risk factor for VCID, specifically, the different mechanisms proposed for homocysteine-induced cognitive decline and the clinical trials aimed at lowering plasma homocysteine.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Dementia
The progression of dementia is generally gradual....
Cognitive Dissonance
Binet's Contribution to Measures of Intelligence
Relative Risk

